mBAT: a newly developed mobile application for self-screening of pediatric bleeding disorders - a multi-center study.

IF 3 3区 医学 Q2 HEMATOLOGY Annals of Hematology Pub Date : 2025-01-15 DOI:10.1007/s00277-024-06178-w
Arpatsorn Sermcheep, Rungrote Natesirinilkul, Patcharee Komvilaisak, Natsaruth Songthawee, Kamala Laohverapanich, Duantida Songdej, Pakawan Wongwerawattanakoon, Praguywan Kadegasem, Ampaiwan Chuansumrit, Nongnuch Sirachainan
{"title":"mBAT: a newly developed mobile application for self-screening of pediatric bleeding disorders - a multi-center study.","authors":"Arpatsorn Sermcheep, Rungrote Natesirinilkul, Patcharee Komvilaisak, Natsaruth Songthawee, Kamala Laohverapanich, Duantida Songdej, Pakawan Wongwerawattanakoon, Praguywan Kadegasem, Ampaiwan Chuansumrit, Nongnuch Sirachainan","doi":"10.1007/s00277-024-06178-w","DOIUrl":null,"url":null,"abstract":"<p><p>Bleeding assessment tools (BATs) are used by trained medical personnel for screening bleeding disorders on a one-to-one basis with patients; hence, they are time-consuming and limited in use for large-population screening. The aims of the study were to develop, validate, and demonstrate a Thai BAT mobile application (mBAT) for self-screening of bleeding disorders. mBAT was developed and validated using the paper-based Thai version of pediatric bleeding questionnaire (TPBQ). Then, mBAT was applied to 916 subjects from communities and hematology clinics. Those with scores of ≥3 consented to further investigation of bleeding disorders. mBAT was developed for Thai children using simple sentences, a video introduction, pictures, and auto-calculation. It showed a high correlation with the TPBQ: r = 0.96 and 0.97 in the PBQ and ISTH scoring systems, respectively (P<0.01). A score ≥3 was considered abnormal. The mBAT was applied to 916 subjects, with a mean (range) age of 10.5 (0.07-18.0) years. Most subjects (97.3%) were from the community, and the rest (2.7%) were from hematology clinics. The results showed 41 subjects had abnormal scores, and 35 (16 from the community and 19 from clinics) consented to diagnostic investigation. Eleven subjects (31.4%) were found to have bleeding disorders, including four with VWD, two each with hemophilia A and thrombocytopenia, and one each with factor VII deficiency, platelet dysfunction, and MYH9-related disorder. Thus, the prevalence rates of bleeding disorders in the subjects whose scores ≥3 from community and hematology clinics were 6.25% and 52.6%, respectively. In conclusions, the mBAT had a high correlation with the TPBQ. As a self-screening tool, it could enhance the diagnosis of bleeding disorders.</p>","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00277-024-06178-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Bleeding assessment tools (BATs) are used by trained medical personnel for screening bleeding disorders on a one-to-one basis with patients; hence, they are time-consuming and limited in use for large-population screening. The aims of the study were to develop, validate, and demonstrate a Thai BAT mobile application (mBAT) for self-screening of bleeding disorders. mBAT was developed and validated using the paper-based Thai version of pediatric bleeding questionnaire (TPBQ). Then, mBAT was applied to 916 subjects from communities and hematology clinics. Those with scores of ≥3 consented to further investigation of bleeding disorders. mBAT was developed for Thai children using simple sentences, a video introduction, pictures, and auto-calculation. It showed a high correlation with the TPBQ: r = 0.96 and 0.97 in the PBQ and ISTH scoring systems, respectively (P<0.01). A score ≥3 was considered abnormal. The mBAT was applied to 916 subjects, with a mean (range) age of 10.5 (0.07-18.0) years. Most subjects (97.3%) were from the community, and the rest (2.7%) were from hematology clinics. The results showed 41 subjects had abnormal scores, and 35 (16 from the community and 19 from clinics) consented to diagnostic investigation. Eleven subjects (31.4%) were found to have bleeding disorders, including four with VWD, two each with hemophilia A and thrombocytopenia, and one each with factor VII deficiency, platelet dysfunction, and MYH9-related disorder. Thus, the prevalence rates of bleeding disorders in the subjects whose scores ≥3 from community and hematology clinics were 6.25% and 52.6%, respectively. In conclusions, the mBAT had a high correlation with the TPBQ. As a self-screening tool, it could enhance the diagnosis of bleeding disorders.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
mBAT:一个新开发的移动应用程序,用于儿童出血性疾病的自我筛查-一项多中心研究。
出血评估工具由受过培训的医务人员用于与患者一对一筛查出血性疾病;因此,它们在用于大规模人群筛查时既耗时又有限。该研究的目的是开发、验证和演示用于出血性疾病自我筛查的泰国BAT移动应用程序(mBAT)。mBAT采用纸质版泰文儿科出血问卷(TPBQ)进行开发和验证。然后将mBAT应用于来自社区和血液科诊所的916名受试者。得分≥3分的患者同意进一步研究出血性疾病。mBAT是为泰国儿童开发的,使用简单的句子、视频介绍、图片和自动计算。PBQ和ISTH评分系统的r值分别为0.96和0.97,与TPBQ呈高度相关(P < 0.05)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Annals of Hematology
Annals of Hematology 医学-血液学
CiteScore
5.60
自引率
2.90%
发文量
304
审稿时长
2 months
期刊介绍: Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.
期刊最新文献
Complete remission induced by rituximab-lenalidomide, following CAR-T cell failure, is not associated with CAR-T cell re-expansion in the peripheral blood. Cost-utility analysis of ropeginterferon alfa-2b to manage low-risk patients with polycythemia vera as compared to phlebotomy only in the Austrian healthcare system. How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024. Molecular landscape of CD8+ T cells in pure red cell aplasia. Genital graft versus host disease in women after allogeneic hematopoietic stem cell transplantation - a single center experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1